# Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor

> **NCT02330497** · NA · COMPLETED · sponsor: **Société Française d'Endoscopie Digestive** · enrollment: 30 (actual)

## Conditions studied

- Pancreatic Tumor
- Endocrine Tumor
- Neoplasms, Cystic, Mucinous, and Serous

## Interventions

- **PROCEDURE:** Radiofrequency Ablation under EUS

## Key facts

- **NCT ID:** NCT02330497
- **Lead sponsor:** Société Française d'Endoscopie Digestive
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02330497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02330497, "Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02330497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*